HSIC · Henry Schein Inc
Price
Snapshot
50 fields · last close| Market Cap | $9.46B |
| P/E | 23.47 |
| Float | 97.22M |
| Beta | 0.87 |
| Volatility | 21.6% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Mid cap |
| Macro sensitivity | Moderate |
| Clavix score | 85.5 |
| Price | 84.88 |
| Change | +0.00% |
| Prev Close | 84.88 |
| Open | 85.18 |
| Day Low | 83.45 |
| Day High | 85.56 |
| Avg Vol | 1 |
| Avg $ Vol | $94.44M |
| 52W High | 92.18 |
| 52W Low | 61.95 |
| 52W Pos | 75.9% |
| From High | −7.92% |
| From Low | +37.01% |
| Max DD 1Y | −17.23% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −1.86% |
| SMA 50 | −3.23% |
| SMA 200 | +5.75% |
| RSI (14) | 42.5 |
| Vol 30D | 19.2% |
| Vol 90D | 20.5% |
| 1Y Range | 62–92 |
| Daily bars | 526 |
| Perf Week | −1.73% |
| Perf Month | −6.10% |
| Perf Quarter | −2.01% |
| Perf Half Y | +14.80% |
| Perf Year | +29.39% |
| Perf YTD | +10.49% |
| Prev Day | +0.00% |
| Clavix | A- |
| Debt / Eq | 0.32 |
| Curr Ratio | 1.38 |
| Int Cover | 5.4× |
| FCF Margin | 5.4% |
| Rev Growth | +4.0% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 2 / 49 |
What HSIC does
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services.
It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services.
The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers.
The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics.
Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Clavix risk grade
regraded every trading dayHSIC grades A-, 85.5 of 100. Steadiest on Price Stability (70), most exposed on News Sentiment (64, mixed). 4 of the 4 weighted dimensions sit above the Health Care median. Ranks 2 of 49 in Health Care by Clavix score.
How rough the ride is
| HSIC | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.87 | 0.85 |
| Volatilityannualized | 21.6% | 21.3% |
| Max drawdown, past yearworst peak-to-trough fall | −17.2% | — |
| Typical daily movemedian absolute daily change | 0.92% | — |
| Days beyond ±3%of the last 252 sessions | 14 (6%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| HSIC | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.87 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| HSIC | |
|---|---|
| 1 week | −1.7% |
| 1 month | −6.1% |
| Year to date | +10.5% |
| 1 year | +29.4% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| HSIC | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 29 Jul |
| Average score0 most bearish, 100 most bullish | 68 |
| Bullish · bearisharticles above 60 · below 40 | 25 · 4 |
| Directionarticles whose tone is improving vs worsening | 25 ↑ 4 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| HSIC | |
|---|---|
| Revenue growthyear over year | +4.0% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openHenry Schein amended and restated its revolving credit facility (a pre-arranged borrowing line the company can draw on as needed), raising total commitments to $1.25 billion and pushing the termination date out to September 19, 2031. The article also notes the stock at $86.37, with a 0.98% gain that day, a 1.80% gain over the week, a 3.52% decline over 30 days, a 12.43% gain year-to-date, and a 30.74% one-year total return. The article body is truncated, so no further details are available.
Henry Schein expanded its revolving credit line by $250 million to a total of $1.25 billion and pushed the expiration date out by more than five years to 2031. A revolving credit facility is a pre-approved loan the company can borrow from and repay as needed.
Henry Schein reported Q2 revenue of $3.46 billion, up 6.7% from a year earlier, with net income and cash flow improving and growth across all business segments. Management raised 2026 guidance to 4.5-5.5% revenue growth and adjusted earnings per share of $5.29-$5.39, and the article notes recent share price gains have outpaced the S&P 500.
Henry Schein (HSIC) was upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects, with the article suggesting this could push the stock higher in the near term.
Zacks upgraded Henry Schein (HSIC) to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| GKOS | Glaukos Corp | B | $9.66B | — | 0.73 | Compare |
| PODD | Insulet Corp | B- | $9.13B | 24.33 | 1.08 | Compare |
| MOH | Molina Healthcare Inc | B | $9.89B | 20.96 | 0.74 | Compare |
| GMED | Globus Medical Inc | B | $10.15B | 18.96 | 0.97 | Compare |
| ALGN | Align Technology Inc | B- | $10.21B | 24.69 | 1.74 | Compare |
| UHS | Universal Health Services Inc | A- | $10.35B | 6.79 | 1.12 | Compare |
| COO | Cooper Companies Inc | B- | $10.82B | 18.98 | 0.83 | Compare |
| HNGE | Hinge Health Inc | C+ | $7.88B | 72.26 | 1.52 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.